The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes
CompletedOBSERVATIONAL
Enrollment
241
Participants
Timeline
Start Date
March 1, 2015
Primary Completion Date
April 12, 2017
Study Completion Date
August 31, 2018
Conditions
Diabetes Mellitus, Type 2Cardiovascular Diseases
Trial Locations (1)
LE5 4PW
Leicester Diabetes Centre, Leicester
All Listed Sponsors
collaborator
University Hospitals, Leicester
OTHER
lead
University of Leicester
OTHER
NCT02694575 - The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter